Revolutionizing Cancer Treatment: The Future of Localized Drug Delivery to Tumors with CEO, Shaun Bagai
Send us a Message In this compelling episode of MedTech 101, host Rodney Moses sits down with RenovoRx CEO Shaun Bagai to explore the latest breakthroughs in cancer treatment. The conversation opens with a clear-eyed look at the challenges pancreatic cancer patients face, before diving into Shaun’s remarkable journey—from aspiring pre-med student to seasoned medtech leader—and the pivotal role engineering plays in redefining cancer care.Rodney underscores the importance of pairing technological innovation with true patient-centric thinking, setting the tone for an insightful discussion on medtech’s ability to transform lives.Shaun explains how RenovoRx is changing the treatment landscape through its patented localized therapy platform, designed to deliver chemotherapy directly to the tumor while reducing life-limiting systemic side effects. Their discussion highlights the development and impact of the RenovoCath catheter and the Trans-Arterial Micro-Perfusion (TAMP) system, technologies that enable precise, targeted drug delivery and bring renewed hope for improved outcomes.Rodney and Shaun also touch on the contrast between the agility of startups and the slower pace of traditional medtech companies—using RenovoRx’s journey to a NASDAQ listing, without being acquired by a larger player, as a powerful example of strategic independence. The episode wraps with optimism about the future of oncology and the transformative potential of smarter drug-delivery systems.Timestamp Summary 00:00 | Innovative Approach to Treating Pancreatic Cancer Locally01:50 | Renovo Rx's Innovative Approach to Localized Chemotherapy Delivery02:31 | From Medtronic to CEO: A Journey in Medical Innovation05:28 | Leveraging Technology in Medicine for Widespread Impact06:47 | RenovoRx's Unique Path in the Medtech Industry12:39 | Innovative Localized Chemotherapy for Pancreatic Cancer Treatment19:22 | Expanding Life-Saving Technology Beyond the US Market21:02 | Innovative Delivery Systems for Pancreatic Cancer TreatmentSupport the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal
-------- Â
23:46
--------
23:46
Redefining Ventilation: How LungPacer Is Reviving the Diaphragm with Neurostimulation
Send us a Message Viral Thakkar, COO of LungPacer Medical, joins Rodney on the MedTech 101 Podcast to discuss how cutting-edge innovation is reshaping ventilator technology. They unpack the limitations of traditional mechanical ventilation and its often-overlooked effects on the diaphragm. Viral shares insights into AeroPace, LungPacer’s breakthrough system that uses phrenic nerve stimulation to help patients breathe and recover more effectively.The discussion dives into the real-world challenges of clinical adoption, the significance of FDA Breakthrough Designation, and what the future holds for ventilation care. Tune in to learn how this technology could redefine outcomes for ICU patients by reducing complications and accelerating recovery.Timestamp00:00 The Impact of Mechanical Ventilation on Diaphragm Health02:02 From R&D to COO: Viral Thakkar's Medtech Journey03:20 A Journey from Personal Tragedy to Medical Device Innovation05:56 Ventilator-Induced Diaphragm Dysfunction and Its Consequences11:38 Innovative Diaphragm Stimulation Technology for Improved Ventilation15:45 Breakthrough Medical Device Designation and Market Challenges19:27 Innovative Ventilation Technology Aims to Improve ICU Patient OutcomesSupport the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal
-------- Â
25:51
--------
25:51
AI’s evolution demands ethics, transparency, and human-centered innovation with Ben Tasker
Send us a Message Ben Tasker, is an AI expert who has transitioned from academia to the utilities sector, focusing on upskilling and reskilling the workforce for the AI era. He discusses his experience developing AI systems for student success prediction in education and cancer risk identification in healthcare.The core themes are:The importance of responsible and ethical AI practices as the technology rapidly advancesThe challenges of getting buy-in from end-users (students, patients, employees) and integrating AI into existing workflowsThe potential of AI to enable more personalized services, especially in healthcare and mental healthThe need to balance the benefits of AI-powered personalization with concerns around privacy, transparency, and the risk of reinforcing biasesOverall, Ben emphasizes the critical role of human-centered design and stakeholder engagement in ensuring AI is implemented effectively and ethically across different industries.Support the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal
-------- Â
33:14
--------
33:14
Bioelectronic Medicine: Entering a New Era of Pain Management Without Pills with Dr Kevin Tracey
Send us a Message Dr Kevin Tracey is a renowned neurosurgeon and the president of the Feinstein Institutes for Medical Research. With over three decades of experience focused on understanding and controlling inflammation. Dr Tracey has pioneered research that led to advancements in bioelectronic medicine. His work explores the potential of the vagus nerve to regulate inflammation, paving the way for innovative treatments for chronic conditions like rheumatoid arthritis. Kevin is also a co-founder of SetPoint Medical, which recently received FDA approval for an implant device aimed at treating inflammation.Timestamp00:00 Bioelectronic Devices Revolutionize Inflammation Treatment04:28 Exploring Bioelectronic Medicine and Innovative Medical Research09:09 Vagus Nerve Stimulation as a Breakthrough in Inflammation Treatment13:07 Implant Revolutionizes Rheumatoid Arthritis Treatment15:56 Vagus Nerve Stimulation and Its Role in Inflammation Control20:25 SetPoint Medical's FDA Approval and Future Distribution Challenges24:08 The Promise of Vagus Nerve Stimulation for Rheumatoid Arthritis27:29 Understanding Present Data to Predict Future Technological Advancements29:48 Vagus Nerve Stimulation as a Future Inflammation Treatment32:16 Podcast Interview with Author Kevin TraceyBook: The Great Nerve: The New Science of the Vagus Nerve and How to Harness Its Healing Reflexes Support the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal
-------- Â
32:29
--------
32:29
Beating Depression with Wearable Headset Technology with Erin Lee
Send us a Message In this episode of the MedTech 101 podcast, host Rodney Moses sits down with Erin Lee, CEO of Flow Neuroscience, to talk about how technology is changing the way we treat mental health.Erin shares the story behind Flow’s groundbreaking device that uses gentle brain stimulation to treat depression, without relying on traditional antidepressants. Together, they discuss the challenges of drug-based therapies and Flow’s mission to make mental health treatment more effective, affordable, and accessible.Erin also opens up about her unconventional journey into medtech, from her time at leading tech firms to her eye-opening experience at Babylon Health, which shaped her vision for digital health innovation.The conversation dives into how Flow operates as a Scandinavian company with a global footprint, spanning the UK, EU, and now expanding into the U.S. market. Erin explains the regulatory hurdles they face, how they navigate them, and what it takes to bring such a device to different regions.She also talks about Flow’s wearable headset — a clinically proven, non-drug treatment that uses targeted electrical stimulation to improve mood. Finally, Erin reflects on the future of mental health care, where AI and medtech could work together to deliver more personalized and accessible treatments for people everywhere.Timestamp00:00 Revolutionizing Depression Treatment Without Antidepressants01:44 Erin Lee's Unconventional Journey to Leading Flow Neuroscience06:07 Innovative Headset Offers Drug-Free Depression Treatment12:17 Challenges and Strategies in Medical Device Market Approvals15:53 Challenges in Introducing Innovative Medical Devices to the Market22:41 The Future of Personalized Brain Stimulation for Depression Treatment29:31 Erin Lee Discusses Neuroscience and Upcoming Device LaunchSupport the showFollow or Connect with Rodney Moses:Instagram | LinkedIn | YouTube | Donations Patreon | PayPal
Discussions about Medical Technology, Pharmaceuticals and popular trends; covering from basic to complex topics in a simplified way to make you understand. Rodney is a Biomedical Engineer and co-inventor working in R&D, ex Johnson & Johnson.